The literature describes monocyte-lymphocyte (MLR), neutrophil-lymphocyte (NLR), and platelet-lymphocyte (PLR) ratios as prognostic biomarkers. However, in the case of dengue infection, patient clinical management and nonspecific laboratory tests determine the prognosis. Therefore, this study analyzed MLR, NLR, and PLR as prognostic biomarkers of dengue infection. Our study was based on a clinical cohort of dengue patients in Brazil between 2012 and 2013. From 193 patients, 164 (85.0%) were classified as dengue fever (DF), 19 (9.8%) as dengue hemorrhagic fever (DHF), and 10 (5.2%) as intermediate DF/DHF. DHF cases were significantly associated with MLR > 0.13 (OR: 5.72, 95% CI: 1.28-25.60, p < 0.05) and PLR ≤ 80.68 (OR: 4.26; 95% CI 1.60-11.33; p < 0.05). Our results suggest that MLR increase, and PLR decrease indicate a higher likelihood of worsening the clinical status.
The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are potential inflammatory biomarkers for prognostic analysis in several diseases, such as type 2 diabetes mellitus (T2DM). This study analyzed NLR and PLR as possible T2DM biomarkers. A cross-sectional study was conducted with a secondary database that included laboratory test results from two healthcare units in Goiânia, GO, Brazil, between 2015 and 2016. The participants were normoglycemic (NG), prediabetic (preDM), and had controlled DM (CDM) and uncontrolled DM (UDM). NLR and PLR were compared between study groups according to sex and age group. NLR was higher in group UDM than preDM (1.88 vs. 1.62, p <0.05) and lower in group preDM than NG (1.62 vs. 1.80, p <0.05). NG women aged ≥65 years were six times more likely to present PLR ≤91.83 than preDM ones (OR: 6.34; CI: 1.98 - 20.55; sensitivity = 41.5%, PPV = 84.6, and LR + = 4.15). NG men aged <65 years were almost four times more likely to present PLR ≤120 (OR: 3.64; CI: 1.21 - 10.89; sensitivity = 80%, PPV = 37.7, and LR + 1.53) than preDM ones. NLR and PLR increases are directly proportional to DM severity, except for group preDM compared to NG for NLR values. These biomarkers can help estimate T2DM prognosis.